RGEN

Repligen Corporation - Common Stock (RGEN)

About Repligen Corporation - Common Stock (RGEN)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Details

Daily high

$182.25

Daily low

$176.22

Price at open

$176.89

52 Week High

$188.73

52 Week Low

$100.99

Market cap

10.0B

Dividend yield

Volume

856,367

Avg. volume

965,121

P/E ratio

241.09

Repligen Corporation - Common Stock News